Global Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Healthcare News

Dr Reddy s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25 - Healthcare News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Prathamesh masdekarCenthaquine lyfaquinReddy laboratories ltdResearch analystAmyris incConsumer healthGovt run janaushadhiBranded marketsEmerging marketsFinancial expressGlobal generics

Dr Reddy s Laboratories Limited (NYSE:RDY) Shares Acquired by Assetmark Inc

Dr Reddy s Laboratories Limited (NYSE:RDY) Shares Acquired by Assetmark Inc
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blue trust incExchange commissionReddy laboratories company profileReddy laboratories limitedAssetmark incReddy laboratoriesLindbrook capitalLaboratories limitedFree reportGlobal genericsPharmaceutical servicesActive ingredientsVisit holdingschannelLaboratories daily

Dr Reddy s Laboratories (NYSE:RDY) Downgraded by StockNews com

StockNews.com downgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, Barclays lifted their price objective on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note on Wednesday, May […]

New zealand generalNew zealandWellington management groupSequoia financial advisorsFisher asset managementReddy laboratoriesAllspring global investments holdingsFree reportGlobal investments holdingsFinancial advisorsManagement groupAsset managementNordea investment managementInvestment managementGet free reportLaboratories limited

Dr Reddy s Laboratories (NYSE:RDY) Cut to Buy at StockNews com

StockNews.com cut shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a research report report published on Thursday morning. Separately, Barclays lifted their price target on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note […]

Healthcare of ontario pension plan trust fundMission capitalReddy laboratoriesBessemer group incReddy laboratories company profilePromethos capitalFree reportStreet groupOntario pension plan trust fundGet free reportLaboratories limitedGlobal genericsPharmaceutical servicesActive ingredientsLaboratories daily

Panagora Asset Management Inc Has $8 34 Million Stock Holdings in Dr Reddy s Laboratories Limited (NYSE:RDY)

Panagora Asset Management Inc. grew its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 47.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 119,794 shares of the company’s stock after buying an additional 38,602 shares during […]

New zealand generalNew zealandSequoia financial advisorsAllspring global investments holdingsWellington management groupReddy laboratories limitedPanagora asset management incExchange commissionFisher asset managementReddy laboratoriesPanagora asset managementLaboratories limitedFree reportAsset managementGlobal investments holdingsFinancial advisors